Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT01007097. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and efficacy of multiple doses of TAK-875, once daily (QD), in subjects with Type 2 Diabetes Mellitus.
Study identification
- NCT ID
- NCT01007097
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 426 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2009 (Type not available)
- Primary completion
- Sep 2010 (Actual)
- Completion
- Sep 2010 (Actual)
- Last update posted
- Apr 13, 2016
2009 – 2010
United States locations
- U.S. sites
- 64
- U.S. states
- 26
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Hoover | Alabama | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Burlingame | California | — | — |
| Not listed | Chula Vista | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Los Gatos | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Pueblo | Colorado | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Panama City | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Sandy Springs | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | La Grange | Illinois | — | — |
| Not listed | Sunset | Louisiana | — | — |
| Not listed | Portland | Maine | — | — |
| Not listed | Parkville | Maryland | — | — |
| Not listed | Rockville | Maryland | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Olive Branch | Mississippi | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Berlin | New Jersey | — | — |
| Not listed | Camden | New Jersey | — | — |
| Not listed | West Seneca | New York | — | — |
| Not listed | Asheboro | North Carolina | — | — |
| Not listed | Burlington | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Morehead City | North Carolina | — | — |
| Not listed | Statesville | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Carlisle | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Perrysburg | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Tipton | Pennsylvania | — | — |
| Not listed | Cranston | Rhode Island | — | — |
| Not listed | Peak | South Carolina | — | — |
| Not listed | Taylors | South Carolina | — | — |
| Not listed | Varnville | South Carolina | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Hurst | Texas | — | — |
| Not listed | North Richland Hills | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Draper | Utah | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01007097, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2016 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01007097 live on ClinicalTrials.gov.